Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chattanooga is a global leader in the design and manufacture of rehabilitation equipment for treating skeletal, muscular, neurological, and soft tissue disorders. Founded in 1947 as the Chattanooga Pharmacal Company, it has grown into a premier brand within the physical therapy and sports medicine sectors. The company's extensive product portfolio includes electrotherapy, ultrasound, traction, and thermal therapy devices, most notably the Intelect and Hydrocollator product lines. Currently operating as a key brand under Enovis (formerly DJO Global), Chattanooga provides clinical solutions used by physiotherapists and healthcare clinics in over 80 countries. Its innovations, such as the VitalStim therapy for dysphagia, have set industry standards for non-invasive rehabilitation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chattanooga International.